Senate approves legislation to address opioid epidemic

Jul 14, 2016 - 03:43 PM

The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Related News Articles

Headline
FDA recalls filters for potential of serious harm; voluntary notice issued for soaps, cleansers
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.…
Headline
Apply to speak at AHA’s Healthier Together Conference
Speakers interested in leading conversations at the AHA’s new Healthier Together Conference are advised to submit a content proposal by Sept. 16. The three-day…
Headline
Webinar to highlight de-escalation in addressing workplace violence
The AHA will host a webinar Aug. 13 from 1-2 p.m. ET that will explore strategies and proven de-escalation techniques unique to addressing workplace violence…
Headline
DOJ announces disruption of BlackSuit ransomware group 
The Department of Justice Aug. 11 announced a series of actions taken against the BlackSuit ransomware group, also known as “Royal,” including the disruption…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces end to IV saline solution shortage 
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues…